caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1700883808

Dean AtkinsonMD

PRACTICEOKLAHOMA ALLERGY & ASTHMA CLINICSee all providers at this practice →
Allergy/ ImmunologyOklahoma City, OKI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,091
Unique beneficiaries
—
Total services
25,591
Distinct HCPCS
10
Medicare payment
$228K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 19 Allergy/ Immunology providers in OK — top quintile (cohort median 16,142).
REFERRAL NETWORK

Where Dean Atkinson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Patricia Overhulser
Allergy/ Immunology · Oklahoma City, OK
111723
Shahan Stutes
Allergy/ Immunology · Oklahoma City, OK
83474
Laura Chong
Allergy/ Immunology · Oklahoma City, OK
78779
MERCY HOSPITAL OKLAHOMA CITY, INC68289
OKLAHOMA HEART HOSPITAL, LLC66261
SSM HEALTH CARE OF OKLAHOMA, INC.38198
Gregory Metz
Allergy/ Immunology · Oklahoma City, OK
28167
NIX, DONALD2226
REGIONAL MEDICAL LABORATORY, INC1952
CROOKS, JAMES1621
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
1319
COMMUNITY HOSPITAL LLC1241
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,791
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
27
Brand share
33.9%
Top prescribed drugs
Montelukast Sodium718 claims
Fluticasone Propionate347 claims
Albuterol Sulfate277 claims
Azelastine Hcl232 claims
Epinephrine159 claims
QUALITY · MIPS · 2024
Final MIPS score
69.2
Quality
49.3
Cost
65.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
-0.69%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
60
By payment type
Food and Beverage$1K
Education$90